Molecular Partners AG (MOLN) — Cash Flow Reinvestment Rate
Molecular Partners AG (MOLN) has a Cash Flow Reinvestment Rate of 0.57x as of March 2022, reinvesting CHF93.61 Million (capex CHF380.00K plus investments CHF-93.23 Million) from operating cash flow of CHF163.56 Million. Explore Molecular Partners AG capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Molecular Partners AG Cash Flow Reinvestment Rate (2015–2022)
Historical reinvestment intensity for Molecular Partners AG across 2 annual periods. Also explore total assets of Molecular Partners AG for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Molecular Partners AG (2015–2022)
Year-by-year capital reinvestment analysis for Molecular Partners AG. For live market cap and broader valuation context, see Molecular Partners AG stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.86x | CHF102.54 Million | CHF118.57 Million | CHF1.42 Million | ▲ +7.0% |
| 2015 | 0.81x | CHF21.41 Million | CHF26.50 Million | CHF1.39 Million | — |